Oxford BioDynamics Plc (AIM: OBD)
Health Care · Life Sciences Tools & Services · GB
£0.00
-13.04% today · -81.0% 1Y
Oxford BioDynamics Plc (AIM: OBD) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $17.79M.
Over the last twelve months the share price has lost 81.0%, trading between 0.00 and 0.01.
Tweenvest scores Oxford BioDynamics Plc across four factors: quality 32/100, value 47/100, growth 100/100. Its strongest factor is growth.
OBD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.79M
- Revenue (TTM)
- $1.58M
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- -0.17
- 52-week high
- £0.01
- 52-week low
- £0.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.44B
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SLS BIO Co., LtdKOSDAQ: A246250 | $19.85M | ₩— | — |
| Genolution Inc.KOSDAQ: A225220 | $19.41M | ₩1,444.00 | -1.70% |
| Promimic AB (publ)OM: PRO | $18.42M | Skr9.60 | -1.54% |
| OncoSil Medical LimitedASX: OSL | $17.93M | AU$0.70 | -11.39% |
| Veritas In Silico Inc.TSE: 130A | $17.45M | ¥426.00 | -1.84% |
| Jeevan Scientific Technology LimitedBSE: 538837 | $17.35M | Rs83.60 | -1.31% |
| Bionano Genomics, Inc.NasdaqCM: BNGO | $16.90M | $1.31 | -8.71% |
| Fusion Antibodies plcAIM: FAB | $16.56M | £0.10 | -2.50% |
Figures last refreshed Oct 11, 2026.